QuidelOrtho Executive and Leadership Team

Micah Young, the Chief Financial Officer at QuidelOrtho, directs all financial strategy and fiscal operations. Overseeing budgeting, forecasting, and financial reporting, Young ensures robust fiscal health and compliance across the organization. This leadership position involves managing capital allocation, investor relations, and driving profitability through strategic financial planning. By optimizing financial structures, Micah Young directly supports QuidelOrtho's expansion in clinical chemistry, immunodiagnostics, and molecular diagnostics. The Chief Financial Officer's oversight extends to risk management and the implementation of financial controls, safeguarding the company's assets and ensuring sustainable growth. Young's expertise underpins the company's ability to fund research and development initiatives, critical for maintaining market leadership in medical technology manufacturing.

Jonathan Siegrist, the Executive VP, Research Development & Chief Technology Officer at QuidelOrtho, architects the company's technological vision and innovation pipeline. Siegrist leads the research and development teams, focusing on advancing equipment for clinical chemistry, immunodiagnostics, molecular diagnostics, and transfusion medicine. This role involves identifying emerging technologies and translating scientific breakthroughs into market-ready solutions. By fostering a culture of innovation, Jonathan Siegrist drives the development of next-generation diagnostic tools that enhance patient care and operational efficiency. The Chief Technology Officer's strategic direction ensures QuidelOrtho remains at the forefront of medical technology, supporting the company's mission to deliver reliable and advanced diagnostic equipment. Siegrist's leadership is pivotal in maintaining a competitive edge through continuous technological enhancement and product evolution.

Philip McLellan, the Chief Operations Officer at QuidelOrtho, directs the company's global manufacturing and supply chain operations. McLellan oversees the efficient production of medical equipment, ensuring quality and timely delivery across all product lines, including molecular and rapid antigen diagnostics. This critical role involves optimizing operational workflows, managing production facilities, and implementing process improvements to enhance efficiency and reduce costs. By streamlining operations, Philip McLellan directly supports QuidelOrtho's commitment to providing reliable medical technologies. The Chief Operations Officer's focus extends to supply chain resilience and logistics management, ensuring uninterrupted service to healthcare providers worldwide. McLellan's leadership is essential for scaling production to meet market demand and maintaining the high standards expected in the medical technology sector.

Nathaniel Sisitsky, the Chief Legal Officer at QuidelOrtho, provides strategic legal counsel and oversees all legal affairs for the corporation. Sisitsky manages regulatory compliance, intellectual property, corporate governance, and litigation, ensuring QuidelOrtho operates within all applicable legal frameworks. This position involves safeguarding the company's interests and mitigating legal risks across its diverse operations in medical technology manufacturing. By ensuring adherence to stringent industry regulations, Nathaniel Sisitsky supports the integrity and trustworthiness of QuidelOrtho's diagnostic equipment. The Chief Legal Officer's expertise is crucial for navigating complex global legal landscapes and protecting the company's assets and reputation. Sisitsky's guidance is fundamental to maintaining ethical business practices and fostering long-term stability for QuidelOrtho.